Stay updated with breaking news from Nasdaq Prct. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
PROCEPT BioRobotics (NASDAQ:PRCT – Free Report) and Nevro (NYSE:NVRO – Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, dividends, risk, analyst recommendations, profitability, valuation and earnings. Earnings and Valuation This table compares PROCEPT BioRobotics and Nevro’s […]
PROCEPT BioRobotics Co. (NASDAQ:PRCT – Get Rating) CFO Kevin Waters sold 22,631 shares of the firm’s stock in a transaction that occurred on Thursday, June 15th. The stock was sold at an average price of $35.12, for a total transaction of $794,800.72. Following the transaction, the chief financial officer now directly owns 33,523 shares in […]
PROCEPT BioRobotics Co. (NASDAQ:PRCT – Get Rating) CFO Kevin Waters sold 22,631 shares of PROCEPT BioRobotics stock in a transaction on Thursday, June 15th. The shares were sold at an average price of $35.12, for a total transaction of $794,800.72. Following the completion of the transaction, the chief financial officer now directly owns 33,523 shares […]
William Blair assumed coverage on shares of PROCEPT BioRobotics (NASDAQ:PRCT – Get Rating) in a research report released on Wednesday morning, The Fly reports. The brokerage issued an outperform rating on the stock. William Blair also issued estimates for PROCEPT BioRobotics’ Q2 2023 earnings at ($0.56) EPS, Q3 2023 earnings at ($0.52) EPS, Q4 2023 […]
William Blair started coverage on shares of PROCEPT BioRobotics (NASDAQ:PRCT – Get Rating) in a research report report published on Wednesday, The Fly reports. The firm issued an outperform rating on the stock. William Blair also issued estimates for PROCEPT BioRobotics’ Q2 2023 earnings at ($0.56) EPS, Q3 2023 earnings at ($0.52) EPS, Q4 2023 […]